News About: Pharm. Industry
Multinational firms urged to abide by fair trade code
The Korea Pharmaceutical Manufacturers Association said that multinational drug manufactures to observe its revised guideline aiming at making the local marketing activities transparent, under the consent of the Fair ...
133 Korean generics deemed expensive
A survey of 133 medicinal products showed that Korean medicines are more expensive than branded products.
The Health Insurance Review and Assessment Service reported recently that a total of 133 generics belonging ...
Ahngook teams up with Biocopea over theobromine
Ahngook Pharma concluded a licensing-out agreement with U.K. based Biocopea Corporation on April 13, 2009, granting Biocopea exclusive patents rights in the U.S. and Europe for the sale of theobromine, a nonnarcotic e...
KPTA to appoint top executives
The Korea Pharmaceutical Manufacturers Association will select the next executives on June 9 after Auh June-sun, the former president, resigned last February in protest against the cash reward plan for doctors and pha...
Oriental medicines' price hike upsets consumers
Starting June 1, leading drug makers raised the prices of the most popular oriental medicines such as “Chungshimwon” in the range of 20 to 25 percent.
It was the company's first price increase in a couple of years...
Hanall acquires local patent for combination bill
Hanall Biopharma said on June 4 that it won a Korean patent for a combination product containing thiazide and angiotensin receptor block for treatment of hypertension.
Hanall said its studies have shown that patien...
Reyon Pharma’s per-share price is set at 16,500 won
Reyon Pharm will make its debut on the bourse on June 10 after its initial public offering (IPO) of 1.3 million shares.
The drug maker said the IPO price is set at 165,000 won.
Reyon succeeded in synthesizing ar...
Keunwha teams up with BioDilivery Science
Kunwha Pharmaceutical said on May 27 it has entered into a license and supply agreement with the U.S.-based BioDelivery Sciences International, Inc. for the exclusive rights to develop and commercialize BEMA Fentanyl ...
Zuellig Pharma Korea to distribute Sanofi Pasteur’s vaccine products
Zuellig Pharma Korea, a regional distributor of pharmaceutical and health care products, said it has enter into a distribution agreement with Sanofi Pasteur and Handok Pharm to initiate the logistic business of vaccin...
LG teams up with Beijing Pharma
LG Life Sciences took a slight but noticeable step to bolster its presence in the rapidly growing pharmaceutical market in China by making strategic partnership with Beijing Pharmaceutical Group.
Executives from bo...
